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, so the LifeAct peptide fused to a fluorescent protein is widely used to localize actin filaments in live cells 2 . However, we find that these fusion proteins have many concentration-dependent effects on actin assembly in vitro and in fission yeast cells. mEGFP-LifeAct inhibits actin assembly during endocytosis as well as assembly and constriction of the cytokinetic contractile ring. Purified mEGFP-LifeAct and LifeAct-mCherry bind actin filaments with K d values of ∼10 µM. LifeAct-mCherry can promote actin filament nucleation and either promote or inhibit filament elongation. Both separately and together, profilin and formins suppress these effects. LifeAct-mCherry can also promote or inhibit actin filament severing by cofilin. These concentration-dependent effects mean that caution is necessary when overexpressing LifeAct fusion proteins to label actin filaments in cells. Therefore, we used low micromolar concentrations of tagged LifeAct to follow assembly and disassembly of actin filaments in cells. Careful titrations also gave an estimate of a peak of ∼190,000 actin molecules (∼500 µm) in the fission yeast contractile ring. These filaments shorten from ∼500 to ∼100 subunits as the ring constricts.
Quantitative studies of actin assembly are essential to understand the mechanisms of endocytosis, cell motility and cytokinesis. Purified actin labelled with fluorescent dyes was used in assays of bulk samples 3 and individual actin filaments 4 that defined the parameters of actin assembly. Many studies have used actin tagged with a fluorescent protein, but these fusion proteins cannot replace the native actin gene 1 . When expressed at low levels, GFP-actin incorporates into cellular structures nucleated by the Arp2/3 complex 1, 5 . However, no GFPactin incorporates into contractile rings in either fission yeast 5, 6 or many other cells 7, 8 (with a few exceptions 9, 10 ). Even tagging actin with a tetracysteine peptide and FlAsH prevents assembly into contractile rings of fission yeast 6 , because the Cdc12p formin that polymerizes contractile ring actin filaments 11 filters out tagged actin 6, 12 . An alternative approach is to express fluorescently tagged proteins that bind actin filaments such as calponin homology domains 13 . It was shown 2 that a peptide consisting of the first 17 residues of the Saccharomyces cerevisiae protein Abp140 fused to a fluorescent protein labels actin filaments in cells. Advantages of this 'LifeAct' peptide include its small size and the lack of homologous genes in organisms other than S. cerevisiae.
LifeAct with fluorescein on its amino terminus binds actin monomers with a K d of 70 nM and actin filaments with a K d of 2.2 µM, without affecting the time course of spontaneous polymerization of bulk samples of pyrenyl-actin 2 . However, more than 1,800 studies have used LifeAct fused to a fluorescent protein for expression in cells at unspecified concentrations, and no studies have documented the effects of LifeAct fusion proteins on interactions with actin or actin filament turnover in cells.
We used fission yeast to test the effects of mEGFP-LifeAct on actin assembly during clathrin-mediated endocytosis 14, 15 and cytokinesis 16 , both precisely timed events in fission yeast. We expressed a wide range of total mEGFP-LifeAct from the strong repressible P3nmt1 promoter (Fig. 1a,b ). These populations of cells grew normally (Fig. 1c) . As observed previously 17, 18 , mEGFP-LifeAct concentrated in endocytic actin patches, cytokinetic contractile rings and actin cables (Fig. 1a) . The total cellular mEGFP-LifeAct influenced the fluorescence intensities of these structures but not their distributions, sizes or shapes, judging from fixed cells stained by Alexa 568-phalloidin (Fig. 1d) , consistent with a previous study 17 . However, mEGFP-LifeAct produced concentration-dependent changes in both endocytosis and cytokinesis. The time to assemble and disassemble (Fig. 1f,g ) actin patches and to assemble (Fig. 2a,b) and constrict ( Fig. 2c,d ) contractile rings increased with the concentration of mEGFP-LifeAct. We used purified proteins to investigate possible mechanisms for these effects on cells. Purified mEGFP-LifeAct and LifeAct-mCherry both bound filamentous actin with a 1:1 stoichiometry and K d values of 9.3 ± 1.0 µM (Fig. 3a) and 13.2 ± 0.7 µM (Fig. 3b) , ∼5-fold weaker than fluorescein-LifeAct (K d = 2 µM) 2 . Thus, neither the position nor the identity of the fluorescent protein influenced the affinity. LifeAct-mCherry slightly increased the anisotropy of Alexa 488-actin monomers, but unlabelled actin did not affect the anisotropy of LifeAct-mCherry. Thus, LifeAct-mCherry interacts very weakly (if at all) with actin monomers.
Consistent with previous work with fluorescein-LifeAct 2 , micromolar concentrations of LifeAct-mCherry had no effect on the assembly kinetics of bulk samples of pyrenyl-actin, but decreased the critical concentration for polymerization slightly ( Supplementary Fig. 1a-d) . Bulk assays measure an ensemble of reactions, including nucleation, elongation, fragmentation and annealing.
Observations of single actin filaments by total internal reflection fluorescence (TIRF) microscopy ( Fig. 3d) revealed that LifeAct-mCherry perturbs many aspects of actin assembly. In spite of low affinities for actin filaments and monomers, submicromolar concentrations of LifeAct-mCherry increased the barbed end elongation rate approximately threefold, whereas higher concentrations slowed elongation (Fig. 3e) . Submicromolar LifeAct-mCherry also increased pointed end elongation from 0.09 ± 0.03 to 0.4 ± 0.1 subunits s −1 . As the addition of actin subunits is diffusion limited 19 , LifeAct-mCherry is unlikely to increase the rate of subunit addition. One possibility is that LifeAct-mCherry promotes elongation by stimulating nucleation, creating short oligomers that grow and anneal to both ends of filaments, very favourable reactions 20 . We used four approaches to test this hypothesis.
First, fluorescence microscopy showed that submicromolar concentrations of LifeAct-mCherry markedly increased the number of filaments formed in reactions containing actin with or without 200 nM formin Bni1(FH1FH2)p (Fig. 3h,i) . The number of filaments peaked at 1 µM LifeAct-mCherry and decreased at higher concentrations.
Second, we tested profilin, which inhibits nucleation but not barbed end elongation 21 . Profilin suppressed the effects of LifeAct-mCherry on elongation of barbed ends (Fig. 3f) and nucleation (Fig. 3i ).
Third, we tested formin FH2 domains, which nucleate actin filaments and remain processively attached to filament barbed ends during elongation 22, 23 . The Bni1p FH1FH2 construct allows elongation at half the normal rate without profilin. Despite increasing the number of filaments formed (Fig. 3h,i) , submicromolar concentrations of LifeAct-mCherry had no effect on the rate of elongation of barbed ends associated with this FH1FH2 construct (Fig. 3g) . High concentrations of LifeAct-mCherry slowed the elongation of Bni1p-bound barbed ends up to 30%, but much less than actin alone.
Fourth, we tested the fission yeast cytokinesis formin Cdc12p, which requires profilin to elongate barbed ends 24 . Barbed ends elongating with Cdc12p and profilin were insensitive to LifeActmCherry (Fig. 3g) .
Thus, independently and together profilin and formins minimize the effects of LifeAct-mCherry on actin filament elongation. Profilin prevents formation of the small oligomers required to make nuclei. Formin FH1FH2 constructs prevent annealing at the barbed end 25 , so short filaments captured by FH2 domains can elongate only by monomer addition. Analysis of the rates of the reactions showed that nucleation and annealing can account for faster elongation ( Supplementary Fig. 1e ). We speculate that LifeActmCherry promotes nucleation by stabilizing actin oligomers by binding to an interface not available in filaments.
LifeAct-mCherry also perturbs interactions of actin filaments with cofilin, a protein important for endocytosis and cytokinesis 26, 27 . Cofilin binds cooperatively to filaments and severs at interfaces between decorated and undecorated segments 28 . Other actin-binding proteins, including Aip1, myosin, coronin, cortactin and Arg kinase, modulate severing activity [29] [30] [31] [32] . Cofilin reduced the affinity of actin filaments for LifeAct-mCherry. Thirty micromolar human cofilin 1 (Hs cofilin) saturated actin filaments 1:1 independent of the concentration of LifeAct-mCherry (Fig. 3c) , so the proteins bind independently to actin filaments. However, LifeAct-mCherry binding to cofilin-saturated actin filaments was cooperative (cooperativity factor ω = 8.8) with much lower affinity (K d = 67 µM; Supplementary Fig. 2a) . Thus, cofilin weakens the affinity of actin filaments for LifeAct-mCherry fivefold indirectly without competing for binding sites.
LifeAct-mCherry can promote or inhibit actin filament severing by cofilin. Concentrations of LifeAct-mCherry well below the K d for binding to actin filaments markedly reduced severing by 20 nM Schizosaccharomyces pombe cofilin (Sp cofilin; Fig. 4a,b) . High concentrations of LifeAct-mCherry also inhibited severing by 5, 10 or 20 µM Hs cofilin (Fig. 4c) , which severs filaments optimally at concentrations 1,000× higher than Sp cofilin. On the other hand submicromolar LifeAct-mCherry concentrations stimulated severing (Fig. 4c ). Higher concentrations of Hs cofilin required higher concentrations of LifeAct-mCherry to stimulate severing (Fig. 4c) .
A thermodynamic analysis (see Methods) shows that LifeActmCherry decreases the affinity of cofilin for an isolated actin subunit fivefold (Fig. 4d, dashed rectangle) , decreases the number of initial (no neighbour) cofilin binding events, and favours nearestneighbour binding of cofilin. These effects suggest that these two proteins produce different, incompatible changes in actin filament structure such as twist 33 and torsional flexibility 34 . It follows that LifeAct inhibits severing (Fig. 4b) by reducing the number of bound cofilins. Such conformational changes are also likely to inhibit filament elongation at saturating LifeAct-mCherry concentrations (Supplementary Fig. 2b ).
Given the effects of mEGFP-LifeAct on endocytosis and cytokinesis, we explored how to use mEGFP-LifeAct to study actin filaments in live cells. The kinetics of actin patch assembly (Fig. 1g) and cytokinesis (Fig. 2b) in cells expressing low concentrations of mEGFP-LifeAct were indistinguishable from normal cells. However, higher cellular concentrations of mEGFP-LifeAct are required to measure the absolute numbers of polymerized actin in cellular structures.
Therefore, we used endocytic patches to test the feasibility of titrating polymerized actin with mEGFP-LifeAct in live cells. As expected for a bimolecular reaction, the average peak numbers of mEGFP-LifeAct per patch increased with the concentration of free mEGFP-LifeAct (Fig. 1h ) measured in parts of the cytoplasm without actin patches or actin cables. The binding curve fit to the data gave a K d = 20.0 ± 3.8 µM (Fig. 1h) , similar to the affinity measured in vitro. Fitting an unconstrained binding reaction to the data extrapolated to a maximum of 7,000 ± 600 mEGFP-LifeAct molecules per patch. If we constrained the K d at 9.3 µM, the value measured in vitro, the binding curve extrapolated to a maximum of 5,300 ± 180 mEGFP-LifeAct molecules per patch (Fig. 1h inset) . Thus, the peak number of 5,000-7,000 mEGFP-LifeAct molecules per patch is consistent with previous measurements made with either GFP-actin 5, 15, 35 or GFP-cofilin 27 . To characterize the assembly and disassembly of actin filaments during cytokinesis, we used low concentrations of mEGFP-LifeAct to measure the time course of actin assembly. Then we benchmarked this data at one time point with an estimate of the number of actin molecules by titration with a range of concentrations of mEGFP-LifeAct.
We measured contractile ring fluorescence in cells expressing 6 µM mEGFP-LifeAct, a concentration that had no effect on the time course of contractile ring assembly (Fig. 2b) . We co-expressed Rlc1p-tdTomato to mark rings and used automated segmentation to separate the mEGFP-LifeAct fluorescence in contractile rings from actin patches (Fig. 5a ). Manually segmenting a sample of cells confirmed that automated segmentation included in rings only 2-3 actin patches per cell, a small fraction of the peak number of polymerized actin molecules in rings that we measured below.
The fluorescence of mEGFP-LifeAct in contractile rings increased steadily during the 25 min maturation stage (Fig. 5b) , peaking just before the onset of constriction (designated as time zero). The mEGFP-LifeAct fluorescence decreased linearly over time as the contractile ring constricted (Fig. 5a,b) , so the density of actin filaments was constant throughout constriction (Fig. 5c ). For comparison, we show that the time course was similar and the fluorescence ∼6-fold higher in a cell expressing 30 µM mEGFP-LifeAct (Fig. 5b,c) .
We used triple GFP tags to count the small numbers of the formins Cdc12p and For3p in rings (Fig. 5d) . Their numbers were constant during the maturation phase and for most of ring constriction, so the ratio of actin to formins declined linearly as rings constricted (Fig. 5e) . The numbers of both formins declined during the last part of constriction.
We used titration to count the number of mEGFP-LifeAct molecules in contractile rings (Fig. 5f ). The maximum number was about 150,000 in cells with the highest concentrations (>10 µM) of free cytoplasmic mEGFP-LifeAct (binned averages, Fig. 5f ). Fitting the binding equation to the dependence of contractile ring mEGFPLifeAct on the free mEGFP-LifeAct concentrations gave a K d of 6.2 ± 1.8 µM and extrapolated to a maximum of 190,000 ± 20,000 mEGFP-LifeAct per ring. If we constrained the K d to 9.3 µM (measured in vitro), the binding curve extrapolated to a maximum of 221,000 ± 8,000 mEGFP-LifeAct per ring (Fig. 5f, inset ). Assuming 1:1 binding, contractile rings contain ∼190,000 polymerized actin molecules. An alternative approach subtracted the contributions from actin patches (Fig. 5g ) from the total fluorescence around the equator to measure actin numbers (Fig. 5g, inset) . This method indicates that the ring is flanked by another ∼94,000 polymerized actins including short-lived whiskers 26 ( Supplementary Fig. 3 ). Electron microscopy of thin sections has provided information about the size and shape of contractile rings since the 1970s 36 , but preserving, resolving and counting individual actin filaments is challenging. Electron micrographs of intact fission yeast cells showed actin filaments in contractile rings 37 , but the data were too limited to estimate the numbers of filaments. The authors of ref. 38 digested the fission yeast cell wall and permeabilized the plasma membrane to allow decoration of actin filaments with myosin subfragment-1. Decorating with myosin stabilized filaments during fixation and revealed their polarity. From electron micrographs of serial sections of six cells they estimated that fission yeast contractile rings contained 1,100-2,100 filaments between 450 and 610 nm long for a total of about 920,000 actin molecules per ring. This larger number may arise from the cell cycle arrest and release used in this work or challenges of measuring actin filaments by electron microscopy.
Knowing the peak number of 190,000 actin subunits in the contractile ring, we calculated that a cross-section of the ring has ∼50 filaments. As the ring is ∼125 nm wide 37 , the centre-to-centre spacing of the filaments is ∼15 nm. During ring constriction, this density of polymerized actin is constant, but the number of actin molecules declines in proportion to the circumference, as first shown by electron microscopy of echinoderm embryos 36 . As the formins Cdc12 and For3p nucleate these filaments 5, 11, 39 , the ratio of actin to formin molecules gives average filament lengths ∼1.4 µm at the onset of constriction and declining linearly as the actin departs before the formins. The 9,000 mEGFP-LifeAct molecules bound at the peak in the time course experiment (Fig. 5b, 6 µM) are unlikely to interfere with the 2,900 Myo2p molecules, 2,000 Myp2 molecules, 500 α-actinin molecules and 1,300 Rng2 IQGAP molecules associated with the ring 5 . Like any probe in any physical system, LifeAct fused to a fluorescent protein is bound to influence actin assembly in cells. One must be aware of the hazards and use probe concentrations that limit its effects. Fortunately, the negative effects on actin patches and cytokinesis depend on the concentration of mEGFP-LifeAct, so minding the concentration allows for its use. Although formins and profilin temper the negative effects, we caution users to measure the concentration of LifeAct fusion proteins in their cells and keep the concentration of LifeAct in the low micromolar range unless they need to measure the total numbers of polymerized actin molecules.
METHODS
Methods and any associated references are available in the online version of the paper. 18 . Cells were grown in EMM5S medium without thiamine for 15-20 h to induce the expression of mEGFP-LifeAct. Heterogeneous expression of mEGFPLifeAct (Fig. 1a) was observed in more than 10 independent experiments. Growth comparisons between the wild type and the cells expressing P3nmt1-mEGFPLifeAct (Fig. 1c) were consistent in repeated experiments. To drive expression of 6 µM mEGFP-LifeAct, we sub-cloned the constitutive adf1 (cofilin) promoter and made a pFA6a-Padf1-mEGFP-LifeAct-KanMX6 vector that was integrated into the leu locus through the standard lithium acetate transformation.
List of yeast strains. QC319: kanMX6-P3nmt1-mEGFP-LifeAct ade6-M210 leu1-32 ura4-D18 (from J. Wu, Ohio State University, USA); QC501: kanMX6-P3nm51-mEGFP-LifeAct rlc1-TdTomato-NatMX6 (made for this study); QC568: for3-3GFP-ura4+rlc1-TdTomato-NatMX6 (made for this study); KV344: cdc12-3XGFP::kanMX6 leu1-32 his3-D1 ura4-D18 ade6-M216 (T.D.P. laboratory stock); QC256: crn1-mEGFP-KanMX6 rlc1-TdTomato-NatMX6 (made for this study); QC500: sad1-mEGFP-kanMX6 kanMX6-P3nmt1-mEGFP-LifeAct rlc1-TdTomato-NatMX6 (made for this study); QC503: rlc1-TdTomato-NatMX6 sad1-mEGFP-KanMX6 (made for this study); QC601: kanMX-Pcof1-mEGFPLifeAct rlc1-tdTomato-NatMX6 (made for this study); QC602: kanMX-Pcof1-mEGFP-LifeAct rlc1-tdTomato-NatMX6 sad11-mEGFP-KanMX (made for this study).
Fluorescence imaging. We imaged live yeast cells on a pad of 25% gelatin in EMM5S with an Olympus IX71 microscope with a spinning-disc confocal unit (Yokogawa, CSU10) and an EMCCD (electron-multiplying charge-coupled device) camera (Andor, X1) calibrated to count the numbers of fluorescent protein molecules in each pixel.
We stained the actin filaments in fixed cells by fixing with 5% formaldehyde for 5 min in TEM buffer (0.1 M Tris-HCl pH 7.4, 1 mM EGTA, 1 mM MgCl 2 ), washing with TEM buffer three times for 1 min each, permeabilizing with 1% Triton X-100 in TEM for 5 min and washing with TEM buffer before treatment with 8 µM Alexa 568-phalloidin (Invitrogen) in TEM buffer for 10 min. Cells were mounted on 25% gelatin pads for microscopy. Cells were also stained with either rhodaminephalloidin or Bodipy-phallacidin with similar results.
We counted actin molecules in cellular structures by titration with mEGFPLifeAct, which binds polymerized actin stoichiometrically (Fig. 3a) . The concept 41 is to vary the concentration of the fluorescent ligand in the cell and measure the numbers of ligand molecules associated with cellular structures, in this case endocytic actin patches and contractile rings. The bimolecular reaction is:
We verified this reaction by measuring bound mEGFP-LifeAct as a function of LA free (LA: LifeAct) and calculating the K d representing the dissociation equilibrium constant.
Fitting equation (1) to the cellular binding data allowed us to estimate LA-FActin when we could not saturate the LifeAct binding site directly.
Image analysis. We analysed fluorescence images with Image J (NIH) and Matlab (Mathworks). We measured the total number of mEGFP-LifeAct molecules in each cell from the total fluorescence in a stack of confocal Z-sections and a calibration curve. The total volume of a cell was calculated from its length as the volume of a cylinder plus a sphere (assuming diameter D = 3.74 µm):
We estimated the length (L) of each cell by measuring the total area of its longitudinal cross-section. We calculated the concentration of LA in the cytoplasm from the total number of mEGFP-LifeAct molecules divided by the cytoplasmic volume of cells, which is 29% of total cellular volume 5 . We calculated the free mEGFP-LifeAct concentration in the cytoplasm from measurements of fluorescence in an area (S) free of actin cytoskeletal structures on the medial slice of Z-series fluorescence micrographs (interval = 0.36 µm) of a cell. The free LifeAct concentration equals the total number of mEGFP-LifeAct molecules in the area divided by the volume (S × 0.36 µm 3 ). We used a computer-assisted semi-automated Image J plug-in to track actin patches in >100 cells in three independent experiments. To measure the number of actin patches flanking the cleavage furrow, we made three-dimensional reconstructions from stacks of fluorescence micrographs of a region of interest 1 µm on both sides of the contractile ring. We counted the numbers of actin patches from two different viewing angles of the furrow and averaged. We segmented contractile rings to count mEGFP-LifeAct with custom NIH Image J macros and Matlab scripts using the fluorescence of Rlc1p-tdTomato to mark the contractile ring. We measured contractile ring assembly in 73 cells and ring constriction in 87 cells. Localization of mEGFP-LifeAct in the cleavage furrow was analysed in more than 50 cells.
An alternative approach to count the number of actin molecules in the contractile ring. The total mEGFP-LifeAct in a band 2 µm wide centred on the cleavage furrow was much higher than in the segmented ring owing to the presence of actin patches, whiskers of actin on the sides of contractile rings and actin cables. We measured the number of actin patches near contractile rings from the fluorescence of mEGFP-Crn1p (coronin). The number of patches was constant at 19 ± 2 (n = 5) during ring constriction (Fig. 5g) . We estimated the numbers of mEGFPLifeAct molecules bound to 19 actin patches at each concentration of cytoplasmic mEGFP-LifeAct from the average number of actin molecules per patch of 3,000 (=6,000/2). Subtracting this number from the total mEGFP-LifeAct at the cleavage site gave the numbers of mEGFP-LifeAct molecules in the contractile ring and other structures flanking the ring at each concentration of mEGFP-LifeAct (Fig. 5g inset) . These counts were about 50% higher than numbers counted by segmenting rings (Supplementary Fig. 3 ), so additional actin filaments flank the ring.
Protein purification. LifeAct-mCherry: LifeAct (sequence: MGVADLIKKFES ISKEE), followed by a linker (sequence: RIPGLIN) and the sequence for mCherry was cloned into a pGEX-4T3 vector, which added an N-terminal GST fusion and a thrombin cleavage site. After cleavage with thrombin, the protein began with Gly-Ser, followed by the LifeAct sequence. The construct was expressed in BL21 DE3 cells with 0.5 mM IPTG (added once the cells reached an optical density of 0.8 at 595 nm) and incubation at 16 • C overnight. After collection, cell pellets were resuspended in 10 ml of 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 1 mM dithiothreitol (DTT) per gram of cells. The cells were lysed by sonication, and ∼100 ml of clarified supernatant was incubated with 6 ml of glutathione-Sepharose resin (GE Healthcare) for 1 h with rotation at 4 • C. The lysate and the resin were then poured into a glass column and the resin was washed with 100 ml of lysis buffer. Fifty units of thrombin (<1% of the concentration of LifeAct-mCherry) were added to the column and incubated at 4 • C overnight. The protein was then eluted with lysis buffer, dialysed into KMEI buffer (50 mM KCl, 1 mM MgCl 2 , 1 mM EGTA, 10 mM imidazole (pH 7.0), 1 mM DTT), flash-frozen and stored at −80 • C. Purified LifeAct-mCherry (up to 50 µM) was incubated with monomeric and filamentous actin for 30 min at room temperature. Analysis of the proteins by SDS-PAGE, Coomassie blue staining and densitometry of bands with ImageJ confirmed that no actin was degraded in the presence of the remaining thrombin.
mEGFP-LifeAct. We sub-cloned the coding sequence of mEGFP-glycineserine-LifeAct into the pGEX6P-1 vector (GE Healthcare) with a Precision Protease cleavage site engineered between the sequences of GST and mEGFP-LifeAct. We induced the expression of recombinant GST-mEGFP-LifeAct in 2-litre cultures of BL21-CordonPlus-RIL cells (Stratagene) with 0.25 mM IPTG overnight at 20 • C. Bacteria were collected and lysed by sonication in 50 ml of lysis buffer (20 mM Tris-HCl pH 8.0, 400 mM NaCl, 1 mM EDTA, 1 mM DTT) with 0.5 mM phenylmethylsulphonyl fluoride and 1 tablet of Protease Inhibitor Cocktail (Roche, eComplete). We incubated 3 ml of glutathione-Sepharose 4B resin (GE Healthcare) with 40 ml of clarified supernatant of the bacterial lysis at 4 • C for 1 h before packing the resin in a 1 × 10 cm column. After washing the column with 10 column volumes of lysis buffer, we incubated the column overnight at 4 • C with 1 ml of lysis buffer containing 50 units of Precision Protease (GST tagged, GE Healthcare) and eluted mEGFP-LifeAct with 9 ml of column buffer.
We measured fusion protein concentrations by absorbance at 280 nm using theoretical extinction coefficients of 34,380 M −1 cm −1 for LifeAct-mCherry and of 21,890 M −1 cm −1 for mEGFP-LifeAct.
Muscle actin. Actin was purified from an acetone powder of frozen chicken skeletal muscle (Trader Joe's) using one cycle of polymerization and depolymerization followed by gel filtration on Sephacryl S-300 and storage in Ca-Buffer-G (2 mM Tris-HCl, pH 8.0, 2 mM ATP, 0.1 mM CaCl 2 , 1 mM NaN 3 , 0.5 mM DTT). The concentration of actin was measured by absorbance at 290 nm with an extinction coefficient of 26,600 M −1 cm −1 . Actin was polymerized in 50 mM PIPES, pH 6.8, 50 mM KCl, 0.2 mM CaCl 2 , 0.2 mM ATP and labelled on lysines by incubating overnight at 4 • C with a 13:1 molar ratio of Alexa Fluor 488 carboxylic acid succinimidyl ester (A-20000, Invitrogen) to actin. After depolymerization, clarification and gel filtration on Sephacryl S-300, purified actin monomers were typically ∼30-50% labelled.
Cofilins. S. pombe (Sp) and human (Hs) cofilin were expressed in BL21(DE3)pLysS cells with 1 mM IPTG at 37 • C for 4 h. About 8 g of cells expressing Sp cofilin were resuspended in 70 ml of 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM DTT, 2 mM phenylmethylsulphonyl fluoride, 1 tablet Roche Protease Inhibitor Cocktail and lysed by sonication. Following clarification of the lysate, Sp cofilin was precipitated with 70% ammonium sulfate, resuspended in 20 ml of 10 mM Tris-HCl pH 8.0, 1 mM NaN 3 , 1 mM EDTA, 250 mM NaCl, and 2 mM DTT and gel-filtered on a 400-ml column of Sephacryl S-200. Peak cofilin fractions were dialysed in 25 mM Tris-HCl, pH 8.4, and 2 mM DTT, loaded on a 20 ml DEAE-Sepharose column and eluted with a 500-ml gradient of 0-500 mM NaCl in DEAE buffer. About 8 g of cells expressing Hs cofilin were resuspended in 70 ml of 10 mM Tris-HCl (pH 7.5), 1 mM EGTA, and 2 mM DTT and lysed by sonication. Following clarification of the lysate by centrifugation at 21,200g for 45 min, the supernatant was applied to a 20 ml DEAE-Sepharose column, and the flow-through of ∼70 ml was dialysed versus 2 l of 150 mM NaCl, 10 mM Tris-HCl (pH 7.5), 2 mM DTT. The protein was then gel-filtered on a 400-ml column of Sephacryl S-200 resin in the dialysis buffer. Following purification, both Hs and Sp cofilin were dialysed in KMEI buffer, concentrated in centrifuge filter devices (Corning Glass, 10-kDa molecular mass cutoff), flash-frozen and stored at −80 • C.
Co-sedimentation assays. We measured affinity and stoichiometry of mEGFPLifeAct and LifeAct-mCherry binding to chicken skeletal muscle actin filaments with a pelleting assay. Actin was polymerized in KMEI buffer and incubated with a range of concentrations of mEGFP-LifeAct or LifeAct-mCherry for 30-60 min at room temperature. Some reactions contained 30 µM Hs cofilin. Reactions were centrifuged at 100,000g for 30 min. Supernatants or pellets from 3 independent experiments were analysed by SDS-PAGE and staining with Coomassie blue. Band intensities were measured with ImageJ software.
TIRF microscopy. Glass flow chambers were incubated for 1 min each with 0.5% Tween 80 in high-salt Tris-buffered saline (HS-TBS; 50 mM Tris-HCl, pH 7.5, 600 mM KCl), 250 nM N -ethylmaleimide-inactivated skeletal muscle myosin in HS-TBS, and 10% BSA (w/v) in HS-TBS, with washes of HS-TBS after each incubation step. Polymerization was initiated by mixing 0.5 µM actin monomers (20% labelled with Alexa 488) with or without formin or profilin and a range of concentrations of LifeAct-mCherry in standard microscopy buffer (10 mM imidazole, pH 7.0, 50 mM KCl, 1 mM EGTA, 1 mM MgCl 2 , 0.3 mM ATP, 15 mM glucose, 50 mM DTT, 0.02 µM CaCl 2 , 20 µg ml −1 catalase, 100 µg ml −1 glucose oxidase, and 0.5% methylcellulose (4,000 cP at 2% (w/v))). Formin-mediated elongation experiments were performed with 200 nM Bni1(FH1FH2)p or 50 nM Cdc12(FH1FH2)p. Bni1p can elongate barbed ends in the absence of profilin, whereas Cdc12p cannot. Therefore, experiments with Bni1p were performed in the absence of profilin, whereas all experiments performed with Cdc12p included profilin. The concentrations of formin used are a reflection of the amount of formin required to nucleate and elongate a sufficient number of filaments for data acquisition and analysis, and do not affect the measured rates. For severing experiments, 0.5 µM actin was polymerized in the chamber until filaments were visible. Unpolymerized monomers were then exchanged with a fresh sample of proteins (that is, LifeAct-mCherry and cofilin) in microscopy buffer, and imaging was continued. Severing data were obtained from 2 to 3 independent experiments that each produced samples containing hundreds of filaments and severing events.
Fluorescence micrographs were collected every 5-10 s using prism-style TIRF microscopy on an Olympus IX-70 inverted microscope and a Hamamatsu C4747-95 CCD (Orca-ER) camera controlled by MetaMorph software (Molecular Devices). Changes in filament length were measured using ImageJ software (National Institutes of Health) for at least 10 filaments in 2 to 4 independent experiments, typically over a span of at least 300 s. We assumed 370 actin subunits per µm of filament 42 .
Thermodynamic analysis of LifeAct-mCherry and cofilin binding to actin filaments. Cofilin binds actin filaments cooperatively, with greater affinity for sites with cofilin bound to neighbouring subunits. These interactions are best described by a model for cooperative binding to singly contiguous (one nearest neighbour) sites with a binding affinity K app ω, where K app is the apparent association equilibrium constant and ω is the cooperativity coefficient. We found that even though LifeActmCherry and cofilin can bind simultaneously to actin filaments, saturating filaments with cofilin decreases their affinity for LifeAct-mCherry (Fig. 3c) . The best fit of a singly contiguous cooperative model to LifeAct-mCherry-actin binding data had a cooperativity factor ω of 8.8, which is similar to the value of ω (8.5) for cofilin binding actin filaments 28 . Using our measured actin-binding constants for LifeAct-mCherry and published parameters for cofilin 40 , we built a thermodynamic model that describes LifeAct-mCherry and cofilin binding to two contiguous filamentous actin subunits (Fig. 4d ). This minimal model describes both an initial binding event (no nearest neighbours) and a subsequent binding event to a site with a bound neighbour. We determined values for unknown binding constants by applying a detailed balance.
The top row of the model defines reactions for cofilin binding to two contiguous actin subunits. The first cofilin binds with a K d of 23 µM to form F_C. Owing to nearest-neighbour cooperativity, the second cofilin binds next to the first with a K d of 1.4 µM. The left column defines reactions for LifeAct binding to two actin subunits. LifeAct does not bind cooperatively to actin in the absence of cofilin, so the binding constants are the same for both binding reactions (13 µM). Other reactions in the scheme define binding of LifeAct to partially and fully cofilin-decorated actin, and vice versa. The affinity of LifeAct for a cofilin-bound actin subunit was determined from the fit to the binding data in Fig. 3c , which produced a K d of 67 µM and a cooperativity factor (ω) of 8.8. As this value of ω is nearly identical to that measured for cofilin, we used the same values of ω + and ω − as reported for cofilin previously 40 to determine the affinity of LifeAct to a cofilin-bound actin subunit with a nearest neighbour bound to LifeAct and cofilin (K d = 4.0).
LifeAct-mCherry decreases the affinity of cofilin for an isolated actin subunit fivefold (Fig. 4d, dashed rectangle) . However, the affinity of cofilin for a binding site with a cofilin-bound neighbour is roughly independent of LifeAct-mCherry. Thus, for a given concentration of cofilin, the number of initial (no neighbour) cofilin binding events decreases in the presence of LifeAct-mCherry, so nearestneighbour binding of cofilin becomes an increasingly predominant mode of filament saturation.
Cofilin is known to alter actin filament twist 33 and increase torsional flexibility 34 . Given non-overlapping sites on actin, the lower affinities of cofilin and LifeActmCherry for actin in each other's presence suggest that these two proteins produce different and incompatible changes in actin filament structure.
Cofilin severs optimally when the number of interfaces between decorated and undecorated filament segments is high. For Sp cofilin, this occurs at nanomolar concentrations, which decorate filaments with a low density of singly bound cofilins 28 . At these concentrations, a fivefold decrease in the affinity of cofilin for binding sites without a neighbouring cofilin will decrease the number of binding events, resulting in fewer decorated segments. This effect ultimately reduces the number of severing events (Fig. 4b) .
On the other hand, reducing the affinity of cofilin for actin sites without a neighbouring cofilin will not affect the extent of filament decoration by concentrations of cofilin that normally saturate actin filaments (for example, 5-20 µM) at equilibrium. However, it is likely to slow the kinetics of cofilin binding to sites without a neighbouring cofilin and therefore the initiation of new decorated segments. This will increase the lifetimes of interfaces between decorated and undecorated segments and increase filament severing in the kinetic regime (Fig. 4c) .
Higher concentrations of LifeAct-mCherry will slow cofilin binding to sites without a neighbouring cofilin, causing an increasing proportion of filament decoration to occur through nearest-neighbour binding of cofilin. This will ultimately result in longer, but fewer decorated segments, and therefore decreased filament severing (Fig. 4c) .
The extent of filament saturation by LifeAct-mCherry in turn depends on the cofilin concentration. As the affinity of LifeAct-mCherry for actin is inversely proportional to cofilin concentration, the concentration of LifeAct-mCherry that produces maximal severing increases with cofilin concentration (Fig. 4c) .
Statistics and reproducibility.
We performed a number of independent experiments to ensure repeatability of our results. Sample sizes and the number of independent experiments are indicated in each figure legend in the manuscript. We did not perform statistical tests. We report standard deviations of the mean where appropriate. 
